T2 Biosystems, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TTOO research report →
About the company
T2 Biosystems, Inc. is an in vitro diagnostics company that develops and commercializes innovative diagnostic solutions for global markets. Its proprietary technology platform enables the rapid detection of pathogens, biomarkers, and other critical abnormalities directly from a wide array of unpurified patient specimens, including whole blood, plasma, serum, saliva, sputum, cerebrospinal fluid, and urine.
- CEO
- Craig R. Jalbert
- IPO
- 2014
- Employees
- 113
- HQ
- Lexington, MA, US
Price Chart
- Market Cap
- $56.09K
- P/E
- -0.00
- P/S
- 0.01
- P/B
- -0.00
- EV/EBITDA
- -0.77
- Div Yield
- 0.00%
- Gross Margin
- -113.58%
- Op Margin
- -690.45%
- Net Margin
- -696.19%
- ROE
- 147.27%
- ROIC
- -230.51%
- Revenue
- $7.19M · -67.75%
- Net Income
- $-50,077,000 · 19.23%
- EPS
- $-19.19 · 98.43%
- Op Income
- $-49,664,000
- FCF YoY
- 5.18%
- 52W High
- $0.15
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.01
- Beta
- 7.87
- Avg Volume
- 5.28K
Get TickerSpark's AI analysis on TTOO
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Nov 4, 24 | LIEBMAN SEYMOUR | other | 25,000 |
| Nov 4, 24 | Giffin Brett A. | other | 180,000 |
| Nov 4, 24 | Adams Laura Lee | other | 25,000 |
| Nov 4, 24 | CUMMING JOHN W | other | 35,000 |
| Nov 4, 24 | Gibbs Michael Terrence | other | 190,000 |
| Nov 4, 24 | Saunders Ninfa | other | 25,000 |
| Nov 4, 24 | Toft Robin | other | 25,000 |
| Nov 4, 24 | Sperzel John J III | other | 490,000 |
| Nov 4, 24 | Elsbree David B | other | 25,000 |
| Nov 4, 24 | Sprague John M | other | 180,000 |
Our TTOO coverage
Recent articles, reports, and earnings notes.
No research on TTOO yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate TTOO report →Similar companies
Peers in the same neighborhood.